Health

In 2025, the adjustment of the national medical insurance drug catalog will add 114 new drugs, and the level of protection in key areas such as rare disease children's medication will be improved

2025-12-08   

Authoritative Release: Today, it was learned from the National Healthcare Security Administration that the National Healthcare Security Administration and the Ministry of Human Resources and Social Security have organized adjustments and formulated the "National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog (2025)" (hereinafter referred to as the new drug catalog) and the "Commercial Health Insurance Innovative Drug Catalog (2025)" (hereinafter referred to as the commercial insurance innovative drug catalog), which were recently issued. The new version of the drug catalog has added 114 new drugs, including 50 Class 1 innovative drugs, while also removing 29 drugs that are not clinically available or can be better replaced by other drugs. After this adjustment, the total number of drugs in the list has increased to 3253, including 1857 western drugs and 1396 traditional Chinese patent medicines and simple preparations. The security level in key areas such as cancer, chronic diseases, mental diseases, rare diseases, and children's drug use has been significantly improved. The first edition of the commercial insurance innovative drug catalog includes a total of 19 drugs, including cancer treatment drugs such as CAR-T, rare disease treatment drugs such as neuroblastoma and Gaucher's disease, as well as Alzheimer's disease treatment drugs, forming a good complementary connection with basic medical insurance. The relevant person in charge of the National Healthcare Security Administration stated that the new drug catalog is the 8th adjustment since the establishment of the National Healthcare Security Administration, and has formed a normalized, standardized, and scientific adjustment mechanism. The new drug catalog will be officially implemented nationwide on January 1, 2026. With more new drugs entering the catalog, the level of clinical medication will steadily improve, effectively boosting the confidence of the pharmaceutical industry to increase research and development innovation, and providing more guarantees for the health of the people. (New Society)

Edit:Wang Shu Ying Responsible editor:Li Jie

Source:Rule of Law Daily

Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email:lwxsd@liaowanghn.com

Recommended Reading Change it

Links